These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1146 related items for PubMed ID: 36454732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.
    Gomes T, Campbell TJ, Martins D, Paterson JM, Robertson L, Juurlink DN, Mamdani M, Glazier RH.
    PLoS Med; 2021 Jun; 18(6):e1003631. PubMed ID: 34061846
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Association of Opioids Prescribed to Family Members With Opioid Overdose Among Adolescents and Young Adults.
    Nguyen AP, Glanz JM, Narwaney KJ, Binswanger IA.
    JAMA Netw Open; 2020 Mar 02; 3(3):e201018. PubMed ID: 32219404
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME, Wood E, Kerr T, Nolan S, Hayashi K, Nosova E, Montaner J, Milloy MJ.
    Drug Alcohol Depend; 2018 Aug 01; 189():90-95. PubMed ID: 29894910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N, DeBeck K, Milloy MJ, Nosova E, Fairbairn N, Wood E, Hayashi K.
    Drug Alcohol Depend; 2018 Dec 01; 193():42-47. PubMed ID: 30340144
    [Abstract] [Full Text] [Related]

  • 15. Opioid Coprescription Through Risk Mitigation Guidance and Opioid Agonist Treatment Receipt.
    Min JE, Guerra-Alejos BC, Yan R, Palis H, Barker B, Urbanoski K, Pauly B, Slaunwhite A, Bach P, Ranger C, Heaslip A, Nosyk B.
    JAMA Netw Open; 2024 May 01; 7(5):e2411389. PubMed ID: 38748421
    [Abstract] [Full Text] [Related]

  • 16. Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
    Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J.
    JAMA; 2022 Mar 01; 327(9):846-855. PubMed ID: 35230394
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Association between trajectories of prescription opioid use and risk of opioid use disorder and overdose among US nonmetastatic breast cancer survivors.
    Chang CY, Jones BL, Hincapie-Castillo JM, Park H, Heldermon CD, Diaby V, Wilson DL, Lo-Ciganic WH.
    Breast Cancer Res Treat; 2024 Apr 01; 204(3):561-577. PubMed ID: 38191684
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.